References
- World Health Organisation. The global burden of disease: 2004 update. Geneva: WHO, 2008
- Pharmaceutical Policy and Analysis Branch. Expenditure and prescriptions twelve months to 30 June 2009. Department of Health and Ageing. Canberra: Australian Government, 2009
- Pharmaceutical Policy and Analysis Branch. Expenditure and prescriptions - Archive. Pharmaceutical Benefits Scheme (PBS) 2009. http://www.health.gov.au/internet/main/publishing.nsf/Content/pbs-stats-pbexp-jun09. Accessed 2 March 2011
- Australian Institute of Health and Welfare. Chronic Disease Indicators Database. 2010. Available at: http://www.aihw.gov.au/cdi/index.cfm. Accessed 3 March 2011
- Moen J, Antonov K, Larsson CA, et al. Factors associated with multiple medication use in different age groups. Pharmacoepidemiology 2009;43:1978–85
- Bjerrum L, Sogaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998;54:197–202
- Malone D, Bhandary D. Factors associated with medication use among the elderly. Abstr Ac Health Ser Res Health Pol Meet 2001;18:157
- Eley DS, Del Mar CB, Patterson E, et al. A nurse led model of chronic disease care - an interim report. Aust Fam Physician 2008;37:1030–2
- WHO Collaborating Centre for Drug Statistics and Methodology. ATC/DDD Index. 2011. Available at: http://www.whocc.no/atc_ddd_index/. Accessed 16 May 2011
- Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108
- Department of Health and Ageing. Schedule of pharmaceutical benefits. Canberra: Australian Government, 2010
- Gujarati DN. Basic econometrics. 4th edn. Sydney: McGraw-Hill, 1995
- Ademi Z, Liew D, Hollingsworth B, et al. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry. Am J Cardiovasc Drugs 2010;10:85–94
- Ademi Z, Liew D, Chew D, et al. Drug treatment and cost of cardiovascular disease in Australia. Cardiovasc Ther Fall 2009;27:164–72
- Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211